Abstract
Aim: To compare the efficacy of a single application of topical 5% permethrin versus a single dose of oral ivermectin in the treatment of scabies. Methodology: Randomized controlled trial. Department of Dermatology, Pak Emirates Military Hospital (PEMH), Rawalpindi, from January 1, 2021, to June 30, 2021. Sixty scabies patients of both genders were included. 30 patients for 5% permethrin cream (group A), and 30 patients for the oral ivermectin group (group B). Follow-up with patients was done at weeks 1 and 2 after treatment. Age in this study was > 5 years. Results: The mean of age was 27.700±8.43 years, duration of disease was 5.133±1.71 weeks, and weight was 71.366±11.31 kg in Group A, while in Group B, age was 30.366±9.37 years, duration of disease was 4.700±1.55 weeks, and weight was 73.433±10.82 kg. Efficacy was observed in 22 (73.3%) patients in group A and 21 (70%) patients in group B (P = 0.775). Conclusion: There is no significant efficacy difference between topical permethrin and oral ivermectin in treatment of scabies. Keywords: Efficacy, Permethrin, Ivermectin, Scabies
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
